Hypertension is a significant contributor to the risk for cardiovascular disease. The increased prevalence of hypertension in women with polycystic ovary syndrome (PCOS) may contribute to the increased risk of cardiovascular disease in these women. Whether hypertension is associated with PCOS independent of obesity remains controversial. Nevertheless, detection and subsequent treatment of hypertension in this population should decrease the adverse sequelae from hypertensive cardiovascular disease. Treatment of risk factors inherent to PCOS, such as hyperandrogenism, insulin resistance, and obesity, may minimize the risk not only for the development of hypertension but also for incident cardiovascular disease independent of hypertension.
|Original language||English (US)|
|Number of pages||17|
|Journal||Endocrinology and Metabolism Clinics of North America|
|State||Published - Jun 2011|
- Polycystic ovary syndrome
ASJC Scopus subject areas
- Endocrinology, Diabetes and Metabolism